Miami International Holdings, Inc. (MIH) and The International Stock Exchange Group Limited (TISE) today announced that they ...
Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback